After successfully rising to the unique challenges of the Covid-19 pandemic, it's time for cancer programs to refocus on the broader ambition: to make cancer care affordable, personalized, and equitable.
Cancer programs have been working toward this for years, but several market forces are driving this ambition more than ever:
- Increasing purchaser focus on controlling costs
- Accelerating pace of clinical innovation
- Growing pressure to prioritize health equity
Learn how to deal with the unprecedented pace of change these challenges present - including how to collaborate across industry sectors - in order to continue providing best-in-class, patient-centered care.